Background--Aerobic exercise (AE) is recommended as first-line antihypertensive lifestyle therapy based on strong evidence showing that it lowers blood pressure (BP) 5 to 7 mm Hg among adults with hypertension. Because of weaker evidence showing that dynamic resistance training (RT) reduces BP 2 to 3 mm Hg among adults with hypertension, it is recommended as adjuvant lifestyle therapy to AE training. Yet, existing evidence suggests that dynamic RT can lower BP as much or more than AE.
H ypertension is the most prevalent, modifiable, and costly risk factor for cardiovascular disease (CVD). 1 Nearly %33% (80 million) of US adults currently have hypertension, 1 and by 2030, this number is projected to reach 41.1%. 1, 2 Lifestyle-related factors have been identified as the only modifiable determinants of hypertension. 2 As a result, numerous randomized controlled trials (RCTs) and over 33 meta-analyses 3, 4 have investigated the antihypertensive effects of exercise. Collectively, these meta-analyses concluded that aerobic exercise (AE) lowers blood pressure (BP) 5 to 7 mm Hg, whereas dynamic resistance training (RT) lowers BP 2 to 3 mm Hg among adults with hypertension. [3] [4] [5] [6] Accordingly, 30 to 60 min/day of moderate-intensity AE is recommended on most days of the week supplemented by moderate-intensity dynamic RT on ≥2 days/week to prevent, treat, and control hypertension. 4, 6 Yet, a more-critical review of this literature revealed considerable variability in the magnitude of the BP reductions following both AE (ie, 1-9 mm Hg) and dynamic RT (ie, 0-6 mm Hg), for reasons that are not clear. 4 In contrast to the strong evidence supporting the BPlowering effects of AE, there is much weaker and limited evidence supporting the efficacy of dynamic RT as stand-alone antihypertensive therapy. 4, 6 In addition to several reviews, [3] [4] [5] [6] 6 meta-analyses to date have exclusively examined the BPlowering effects of dynamic RT, [7] [8] [9] [10] [11] [12] which included mostly healthy adults with normal BP and prehypertension. Importantly, none of these meta-analyses completely satisfied contemporary methodological quality standards 3,13-15 nor were they able to identify important sample or dynamic RT characteristics that modulated the BP response to dynamic RT. Meta-analyses routinely cited poor reporting, 7, 9 low methodological study quality, 10, 11 and the small number of RT studies 7, 8, 10, 11 as limitations of their meta-analyses, and hence, lack of significant findings. Yet, meta-analyses rarely examined how methodological study quality influenced their study results, 8, 10, 11 applied stringent inclusionary criteria, 9, 10, 12 and used subgroup analysis to investigate potential moderators, an approach that is less precise than other conventional techniques, especially among small samples. [16] [17] [18] [19] Because of these notable limitations, previous meta-analyses likely underestimated the antihypertensive effects of dynamic RT, calling into question the generalizability of their findings to adult populations with high BP. 3, 4 Several primary level studies have shown that systolic BP (SBP)/diastolic BP (DBP) reductions following dynamic RT are comparable to that of AE among adults with hypertension, 20 reporting SBP/DBP reductions of %7 to 16/6 to 12 mm Hg and %10 to 14/1 to 4 mm Hg among adults with untreated [21] [22] [23] and controlled [24] [25] [26] hypertension, respectively.
Although limited, controlled studies directly comparing the effectiveness of AE and dynamic RT as antihypertensive therapy found that dynamic RT reduced BP to similar levels as AE 20 among adults with untreated (%7-14/6-8 mm Hg) 21, 23 and controlled (%10/3 mm Hg) 24, 27 hypertension.
Therefore, the purposes of our meta-analysis were to provide more precise estimates regarding the efficacy of dynamic RT as stand-alone antihypertensive therapy, and identify potential moderators of this response to provide insight into the optimal dose of dynamic RT to lower BP among adults with high BP.
Methods
This study fully satisfies the criteria implied by the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), 14, 15 AMSTAR Methodological Quality Scale (Assessment of Multiple SysTemAtic Reviews), 13, 28 and AMSTAR ExBP , an augmented version of the AMSTAR designed specifically to assess meta-analyses examining the BP response to exercise. 3 Institutional review board approval was not required for the current research because it is a meta-analysis of controlled dynamic RT interventions, which is not considered as research involving human subjects.
Inclusion Criteria
Controlled studies were eligible for inclusion if they satisfied 4 a priori criteria: (1) involved adult participants (≥19 years); 29, 30 (2) involved a non-exercise/non-diet control or comparison group; (3) reported BP pre-and post-intervention for dynamic RT and control groups; and (4) reported the Frequency, Intensity, and Time (or FIT) of the dynamic RT intervention. Studies involving weight loss drugs, diet therapy, or diet modifications in addition to dynamic RT were excluded. Approximately half of US adults (49.8%) 31 have at least 1 lifestyle-related chronic health condition (eg, diabetes mellitus, CVD risk factors, etc, that require ongoing medical attention and/or limits activities of daily living 32, 33 ), and of these, another half (25.5%) have 2 or more of these conditions. 31 Given that hypertension usually occurs in conjunction with other metabolically linked CVD risk factors (ie, <20% occurs in isolation), 34 and more than half of adults with hypertension have a cluster of 2 or more CVD risk factors, 34 we only excluded studies that involved populations with disease(s) or health conditions unrelated to CVD (eg, arthritis, cancer, HIV/AIDS).
Search Strategy
In consultation with a medical librarian (J.L.), exhaustive Boolean searches were run in 5 electronic databases from inception until January 31, 2014 to identify all relevant studies. Potentially qualifying reports were retrieved from the following electronic databases: Cumulative Index to Nursing and Allied Health Literature, PubMed (including Medline), Scopus (including EMBASE), SportDiscus, and Web of Science (online supplemental material, Data S1, provides the full search strategy for each electronic database). Four investigators (H.V.M., T.U.G., K.C.F., and L.M.L.) screened the sample for inclusion with duplication of effort. Reference lists of included studies, relevant reviews, and meta-analyses were manually searched for additional reports.
Data Extraction and Coded Variables
Coded variables were extracted using a standardized coding form and coder manual previously developed by a team of experts (L.S.P., B.T.J., T.B.H.M) and pilot tested. Two trained coders (H.V.M., K.C.F.) independently extracted and entered study information with high reliability across all dimensions (mean Cohen j=0.86 for categorical variables; 35 mean Pearson r=0.94 for continuous variables); all disagreements were resolved by discussion. Coded variables included methodological study quality and characteristics of the study, sample, and dynamic RT intervention. Only 14% of the studies 21, 24, [36] [37] [38] [39] [40] [41] [42] disclosed the race/ethnicity of their study participants. When unreported, race/ethnicity was estimated using study location; [43] [44] [45] samples were considered "white" for North America, Europe, and Australia; "Asian" for Asia and India; "Hispanic/Latino" for South and Central America; and "Black" for Africa. Approximately one-third of studies failed to disclose information regarding BP medication use among their study participants. Similar estimates were observed among studies that did not report BP medication use (k=22) and those that reported no BP medication use among their sample (k=35; P>0.05); therefore, these studies were combined (k=57) for subsequent moderator analyses. Chronic diseases and health conditions related to CVD were categorized based on the total number reported in the sample. 31, 46 Studies that reported ≥2 chronic diseases/health conditions among their sample were categorized as having "multiple chronic conditions." 32, 33 Methodological quality of the studies in our sample was assessed using a modified version of the Downs and Black Checklist 47, 48 (see Data S2 for the augmented checklist). This instrument 49 is well validated in the health promotion literature and is reliable for assessing both RCTs and nonRCTs. 50 The Downs and Black checklist addresses 5 subscales of quality (ie, reporting, external validity, bias, confounding, and power) and is considered one of the most comprehensive instruments available for assessing methodological study quality. 50 The overall methodological quality was gauged as percentage of items satisfied out of a possible 29-point total and was quantified as: low (≤14 points, <50%), moderate (>14-23 points, 50-79%), or high (≥24 points, ≥80%). 47, 48 In addition to quantifying the quality of the dynamic RT literature, we examined how overall methodological quality, quality subscales, and individual dimensions of quality influenced the BP response to dynamic RT independently and interactively 51 with other moderators.
Study Outcomes and Effect-Size Calculation
Standardized mean difference effect size (d) was used to quantify the effectiveness of dynamic RT as stand-alone antihypertensive therapy, defined as the mean difference in resting SBP/DBP between dynamic RT and control groups post-versus pre-intervention divided by the pooled SD, correcting for small sample size bias and baseline differences. 52, 53 We disaggregated comparisons for studies with >1 dynamic RT interventions (eg, high vs low intensity RT); 42, [54] [55] [56] [57] [58] [59] ds were calculated for each comparison (k) and analyzed as separate studies. 60 Negative d values indicated that dynamic RT reduced BP more than the non-exercise control group, and the magnitude of d values was interpreted as À0.20, À0.50, and À0.80 for small, medium and large BP reductions. 61 Last, we provide the unstandardized mean effect size (ie, BP difference in mm Hg between RT and control groups at postversus pre-intervention) 60, 62 as a supplement to d in order to enhance the clinical utility of our findings.
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Inconsistencies in ds were estimated with the Q statistic 64 and transformed into the I 2 statistic and its 95% CIs. 65, 66 I 2 values range from 0% (homogeneity) to 100% (greater heterogeneity); a CI that does not include 0% indicates that the hypothesis of homogeneity is rejected, and an inference of heterogeneity is merited. 65, 66 Moderator Analyses
Given the considerable variability in the magnitude of the BP reductions observed following exercise training (ie, 0-9 mm Hg), 4 we examined theoretically driven, a priori study-level moderators (ie, effect modifiers) related to characteristics of the study (eg, methodological study quality, BP-focused outcome), sample (eg, baseline BP, race/ethnicity), and dynamic RT intervention (eg, the FIT, number of RT exercises) to determine what combinations elicited the greatest BP reductions. Weighted regression models (viz, meta-regressions) with maximum-likelihood estimation of the random-effects weights, the inverse of the variance for each d, were used to explain the variability in ds for SBP and DBP. Continuous moderators were mean centered and categorical variables were contrast coded before generating interaction terms or performing multiple moderator analyses. 51, 67 Multiple moderator meta-regression models
Because meta-analysis is correlational in nature, we did not rely solely on individual bivariate metaregressions to "prescreen" which a priori, theoretically driven, study-level moderators would be examined in multiple moderator models. 18, 51, 68 In addition to identifying significant or trending (P≤0.10) moderators in bivariate meta-regression, we also examined the model coefficient and R 2 value (ie, proportion of variance explained by the covariate) for individual moderators to gauge its influence on the BP response to RT.
The moving constant technique
Although it is commonly ignored in practice, 67 
Additive model
For both SBP and DBP, an additive model was generated from the final multiple moderator model that represented the greatest potential antihypertensive benefit that could be achieved with dynamic RT. In this approach, individual moderators and interaction terms are evaluated simultaneously at the level (ie, b d þ and 95% CIs) that confers the largest BP reductions, which in turn, identifies the combination of study-level moderators, including sample and dynamic RT characteristics, that elicits optimal antihypertensive benefit. In order to facilitate clinical interpretations, we transformed our results arithmetically to provide the equivalent BP change in mm Hg. For each moderator dimension and level of interest, we back-converted the standardized estimate (ie, b d þ ) into mm Hg of BP change by multiplying the predicted d values by the SD corresponding to the BP level of interest. 63 Specific transformation details appear in the table footnotes.
Publication Bias
We visually examined funnel plots for any asymmetries in the effect-size distribution to identify potential publication or other reporting biases. 77 We also evaluated the potential for publication bias using Begg 78 
Sensitivity Analyses
To determine whether multiple treatment studies (ie, nonindependent effect sizes that result from different RT interventions being compared to a single control group) 80 influenced our weighted mean estimates and multiple moderator meta-regressions, we performed alternative analyses in R 81 using the metafor package (viz, rma.mv function).
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Multivariate meta-analytic models, following random-effects assumptions with maximum-likelihood estimation that accounted for these issues, yielded the same pattern of results (see Tables S1 and S2 for the multivariate mean estimates and multiple moderator models). For simplicity of interpretation, we only report the maximum-likelihood estimation analyses for SBP and DBP below.
Statistical Computing
Continuous variables are summarized as meanAESD, unless otherwise stated, and categorical variables are presented as absolute values and percentages. Differences in baseline characteristics between the dynamic RT and control groups were examined using t-tests, Table S3 provides a general description of each study, sample, and intervention characteristics for the dynamic RT and control groups. Included RT studies were published between 1987 and 2013, the majority were RCTs (82%), and approximately half examined BP as a primary study outcome (48%). Most interventions involved a non-exercise/wait-listed control group (86%); 9 studies involved a "placebo" control/comparison group † (Table S3) .
Study Characteristics
Included studies achieved "moderate" methodological study quality (%63%), 47, 48 despite widely varying scores (41-85%; see Table S4 ). Studies were most likely to satisfy reporting (78.6%) and internal validity (bias=70.2% and confounding=51.5%) quality subscales, but least likely to satisfy external validity (46.5%) and power (9.2%). None of the subscales emerged as significant moderators in analyses; only 7 studies satisfied ≥80% of quality items (%83.3%; see Table S5 for the overall and itemized summary of methodological study quality for each intervention). than hypertension (7 studies; N=161); 36, 55, 90, 91, 101, 114, 118 11 studies (17.2%) reported a clustering of ≥2 chronic diseases and/or health conditions among their sample (see Tables 1  and S3) . Of the 9 studies that reported race/ethnicity (N=446), 6 included all 37 included a small proportion of African American/Black participants (N=9), and 5 21, 36, 40, 42 included "other" participants (N=25 ; Table S3 ). When we combined the reported and estimated race/ethnicity determinations, the included studies yielded a diverse sample that consisted of 56.7% white (N=1329) and 43.3% non-white samples (N=1015), that is, 21.2% Hispanic/Latino (N=497), 20.9% Asian (N=490), and 1.2% Black (N=28). Baseline sample characteristics were similar between the dynamic RT and control groups (Table 1) . Table 2 ). On average, dynamic RT programs prescribed 2.8AE0.9 sets of 11.0AE3.8 repetitions for 7.9AE2.9 dynamic RT exercises per session. One-fourth of studies (27%) failed to disclose the level of supervision during the dynamic RT intervention; of those that did, 63% reported direct supervision. The overall adherence to dynamic RT was high (92.3%AE8.9%), but adherence was only reported in 65% of the studies.
Sample Characteristics

Dynamic RT Intervention Characteristics
Resting BP Assessment
Most interventions reported the instrument used to assess BP (81.7%), with BP most commonly measured in the seated (42.3%) or supine (26.8%) position. Yet, %69% of the dynamic RT interventions did not report these details (see Table S6 ).
Dynamic RT as Stand-Alone Antihypertensive Therapy lacked homogeneity (see Figure S3 for contour-enhanced funnel plots, a visual display of the effect-size distribution). Table S7 summarizes the weighted mean effect size and tests for homogeneity for the control, dynamic RT, and dynamic RT versus control.
Moderator Analyses: Multiple Moderator Models
Multiple moderator SBP model SBP reductions were greater among studies involving samples with higher resting SBP (P=0.011), which occurred in a doseresponse fashion: 5.7 mm Hg for samples with hypertension, 3.0 mm Hg for samples with prehypertension, and 0.0 mm Hg for samples with normal BP. SBP was also reduced to a greater extent among studies involving nonwhite than white samples (P=0.002), and among study samples that were not taking BP medication versus those that were (P=0.034). Greater SBP reductions occurred among studies that prescribed ≥8 versus <8 dynamic RT exercises/ session (P=0.043), and among studies that examined BP as a primary outcome versus those that did not (P=0.032; Table 3 ). Collectively, these study-level moderators accounted for %67% of the variance in the BP response to dynamic RT.
Additive SBP model
Dynamic RT elicited the greatest potential SBP benefit among studies that included samples with untreated hypertension and prescribed ≥8 dynamic RT exercises/session (À11.8 mm Hg; 95% CI, À16.0, À7.4), an effect that was significantly greater among studies involving non-white than white samples (see additive SBP model, bottom of Table 4 ). Collectively, these study-level moderators accounted for %50% of the variance in the BP response to dynamic RT.
pronounced among studies involving non-white than white samples (see additive DBP model, bottom of Table 4 ).
Discussion
Our meta-analysis aimed to determine the efficacy of dynamic RT as stand-alone antihypertensive therapy and identify potential moderators of BP response to provide insight into the optimal dose of dynamic RT to lower BP among adult populations with high BP. Consistent with past metaanalyses, 5, [8] [9] [10] 12 we found that moderate-intensity dynamic RT, on average, reduced BP %2 to 3 mm Hg compared to control (Ps<0.001). Importantly, our moderator analyses revealed new study-level findings that merit further comment. Our meta-analysis revealed that dynamic RT can elicit BP reductions that are comparable to, and in some cases greater 12 and adhered to high-quality, contemporary standards. 3, [13] [14] [15] Another important distinction between ours and previously published meta-analyses [7] [8] [9] [10] [11] [12] is that we applied less common, but more sophisticated, contemporary approaches, such as multiple moderator meta-regressions, 16, 18, 19 interactive modeling strategies, 51 and the moving constant technique. 67 In contrast, past meta-analyses have almost exclusively used subgroup or univariate meta-regression analyses to investigate potential study-level moderators. These 2 approaches consider moderators individually rather than collectively, 16, 18, 19 which is problematic not only because metaanalysis is correlational in nature, 16, 18 but also because the BP response to exercise is complex and is likely influenced by many factors at both the study and individual level.
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Assessing multiple study-level moderators in a single metaregression model is the preferred method because it allows sample, RT intervention, and study-quality moderators that explain unique variance in the BP response to exercise to be isolated with greater precision and confidence. 16, 18, 19, 51, 68 Furthermore, the use of contemporary strategies, in particular the moving constant technique, 67 can estimate the magnitude of BP reduction at different levels of individual moderators, thus providing more precise estimates that can facilitate interpretation of their clinical significance. Our meta-analysis is the first in the exercise and BP literature to incorporate methodological study quality quantitatively to determine whether it independently 3, 13 or interactively 51 modulates the BP response to dynamic RT. We found that BP reductions were greater among studies that achieved lower than higher methodological quality, although there was a paucity of higher-quality dynamic RT studies in this literature, with only 7 satisfying ≥80% of quality items. We also found that, despite overall quality, greater BP reductions occurred among studies that examined BP as a primary outcome. We, along with past meta-analyses, [10] [11] [12] have found this literature to be of "fair-to-moderate" methodological study quality. 47, 48 In the absence of a higher-quality literature, there is the potential risk of bias or other threats to validity. Therefore, in addition to assessing and controlling for methodological study quality and whether studies had BPfocused outcomes in our multiple moderator models, we examined other sources of potential bias. We found that higher methodological quality was associated with morerecent studies (r=0.45; P<0.001), RCTs (r=0.23; P=0.052), studies that were adequately powered to detect BP outcomes (r=0.41; P<0.001), involved 1 dynamic RT intervention (vs multiple; r=0.22; P=0.069), and followed established BP assessment protocols (r=0.24; P=0.045). Despite their 
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Moderate and higher quality. ¶ Indicates the moderator dimensions/levels that conferred the largest DBP reductions and were used to generate the additive DBP model. association with methodological study quality, none of these potential biases modulated the BP response to dynamic RT. Nonetheless, they were incorporated in analyses, when feasible, to control for confounding or suppression effects that could arise from lower-quality studies. 3, 51 By examining the potential risk of bias from several sources and incorporating them into our multiple moderator models, we can be more confident in our results, despite the number of methodological deficits and inconsistencies in this literature. 51 Our moderator analyses also addressed other important gaps in this literature. No meta-analysis conducted to date, until ours, has identified features of the dynamic RT intervention that influences the BP response to dynamic RT. We found that dynamic RT protocols performed, on average, 3 days/week using low-to-moderate loads/intensity (%60-65% 1-RM), consisting of 3 sets of 10 to 12 repetitions for %8 (3-4 upper and 4-5 lower body) exercises significantly reduced resting BP %5 to 6 mm Hg among studies that included samples with hypertension. We observed even larger BP reductions among studies that prescribed dynamic RT ≥3 versus <3 days/week and ≥8 versus <8 RT exercises/ session. Our findings are in agreement with the current exercise recommendations for hypertension, and provide some of the first study-level evidence regarding the FIT components of the dynamic RT prescription for adult populations with high BP. Nonetheless, important characteristics of the dynamic RT intervention (eg, progression, load/intensity, rest/recovery duration) were inconsistently or poorly reported. Therefore, the dynamic RT protocol that elicits the most favorable BP benefits for adult populations with hypertension remains elusive. We also identified study-level sample characteristics that suggests there may be particular populations that could benefit the most from dynamic RT as stand-alone antihypertensive therapy. Namely, BP reductions were greater among study samples that were not taking antihypertensive medications compared to those that were (%4 vs 1 mm Hg), independent of baseline BP. This finding is potentially promising because of the synergistic effect between antihypertensive medication and the magnitude of BP reductions following dynamic RT that have been reported by some, 25, 132, 133 but not all, studies. 22, 121, 122 Nonetheless, these findings should be interpreted with caution given the small proportion of dynamic RT studies that reported antihypertensive medication use in their sample (%15%), and the generally poor reporting of medication use in this literature (unreported by %33%). Interestingly, we found that dynamic RT studies involving non-white (ie, Asian, Hispanic/Latino, and Black) samples with hypertension elicited BP reductions of 10 to 14 mm Hg, approximately double the magnitude that has been previously reported to occur as a result of AE training among predominately white populations (ie, 5-7 mm Hg). [3] [4] [5] [6] To the best of our knowledge, only 1 meta-analysis 43 has investigated the potential impact of race/ethnicity on the BP response to exercise training. Whelton et al 43 found that AE training reduced resting BP to greater levels among Asian (6/ 7 mm Hg) and Black (11/3 mm Hg) compared to white samples (3/3 mm Hg; P<0.05). In follow-up analyses (not shown), we observed a similar non-significant trend where greater SBP reductions occurred among studies that included Hispanic/Latino (%13/10 mm Hg) and Asian (%11/ 10 mm Hg) compared to white samples (%9/10 mm Hg). The potential mechanisms underlying the greater BPlowering benefits resulting from dynamic RT among non-white than white samples are beyond the scope of our metaanalysis, and should be interpreted with some caution because we estimated race/ethnicity based on the study location for %86% of included studies. Nonetheless, we examined racial/ethnic differences in baseline study-level characteristics to determine whether these covariates could provide additional insight to our findings. Despite similar baseline BP (white: 128.0AE9.9/76.9AE8.9 mm Hg vs nonwhite: 125.0AE10.6/76.6AE8.7 mm Hg; Ps≥0.90), we found that body mass index was higher among studies with white than non-white samples (27.9AE0.5 vs 25.6AE0.6 kg/m 2 ;
P=0.01), and waist circumference tended to be greater among non-white than white study samples (100.1AE8.2 vs 92.2AE9.5 cm; P=0.10). However, these study-level covariates did not emerge as moderators of BP response to dynamic RT, perhaps in part, because they were poorly reporting across interventions (body mass index, k=60; waist circumference, k=17). Therefore, follow-up analyses did not provide any additional insight into our findings as to why greater antihypertensive effects were observed among RT studies that included non-white than white samples.
Limitations, Strengths, and Future Directions
Our meta-analysis is not without limitations. The broader selection criteria, which permitted RCTs and non-RCTs and studies that included samples with and without CVD-related chronic diseases and health conditions, may limit our ability to directly compare our findings against previous meta-analyses. On the other hand, subsequent analyses did not reveal that randomization or inclusion of study samples with CVD-related chronic diseases or health conditions significantly modulated the BP response to dynamic RT. Moreover, our multiple moderator models controlled for potential biases that could have been introduced by including studies presumed to be of "lower quality" (ie, non-RCTs). We must also acknowledge that estimating race/ethnicity based on the geographical location of the study is a limitation of our meta-analysis, but more importantly, a limitation of primary-level studies in this literature. [134] [135] [136] We estimated race/ethnicity only when it was unreported in the original article; unfortunately, this was the case for the majority of our sample. Nonetheless, we employed the same methodology used by Whelton et al 43 and
2 recent meta-analyses that examined differences in prevalence of high BP 45 and diabetes mellitus 44 between racial/ ethnic minority groups. Finally, our results should be interpreted with some caution because the effect modifiers we observed using study-level moderators may not be confirmed in future studies using individual participantlevel.
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Our meta-analysis also has several strengths. In addition to fully satisfying contemporary methodological standards, our meta-analysis is one of the largest, most comprehensive meta-analyses conducted on this topic to date. We included 64 controlled studies (71 interventions) that involved 2374 participants, of which 1968 had pre-to established hypertension. Second, we expanded upon previous meta-analyses by applying more sophisticated, contemporary approaches (ie, multiple moderator meta-regressions 16, 18, 19 ) and innovative techniques (ie, interactive modeling strategies 51 and the moving constant technique 67 ) that enabled us to identify novel study-level moderators that explained a clinically meaningful proportion of the variance in the BP response to dynamic RT (ie, 50-67%). Third, our meta-analysis incorporated methodological study quality and other potential biases (ie, BP-focused outcomes) into our multiple moderator models; therefore, we can be more confident in the robustness of our findings despite the methodological limitations of this literature. Last, our results may also help to optimize future research efforts by documenting where knowledge is the weakest or poorly reported, generating new hypotheses about what dose of dynamic RT elicits optimal antihypertensive benefits for particular patient populations, and highlighting which research areas warrant additional investigation.
Conclusions
In summary, our meta-analysis, which adhered to high-quality, contemporary methodological standards, revealed that dynamic RT can elicit BP reductions that are comparable to, or greater than, those reportedly achieved with AE among samples with hypertension. A novel finding was that dynamic RT conferred the greatest antihypertensive benefit among studies that included non-white samples with hypertension that were not taking BP-lowering medication; BP reductions that were double in magnitude to those reported as a result of AE training. Despite our new and exciting findings, this literature has limitations and is of only fair-to-moderate quality. Additional RCTs that adequately report the characteristics of their sample, dynamic RT intervention features, and BP assessment methods are needed to confirm our findings. Nonetheless, our results indicate that RT should be further investigated as a viable lifestyle therapeutic option for adult populations with hypertension, and the present exercise recommendations for hypertension should be revisited to include dynamic RT in addition to AE as stand-alone antihypertensive lifestyle therapy. PubMed was searched with appropriate Medical Subject Headings (MeSH) incorporated into hedges. Filters were set for Humans:
("mean arterial" OR "blood pressure"[mesh] OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR antihypertensive OR hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement") AND ("exercise" OR treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination training" OR "combined training" OR plyometric Web of Science was searched using the following terms as "Topic" words. Filters were set for Document Type, including only: Articles, Proceedings Papers. Due to database limitations, excluded terms (i.e., "NOT" terms) were only searched in the article titles, and was performed using RefWorks.
Line 1 (in topic): ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement") AND Line 2 (in topic): (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination training" OR "combined training" OR plyometric* OR HIIT OR swimming) OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR cycling OR walking) AND Line 4 (in topic): ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR controlled) NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR "activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR "Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR "drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "crosssectional" OR "case report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR "cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats OR "epidemiology") SportDiscus was searched for the following terms as "Topic" words. Filters were set for Publication Type, including only: Journal Articles; Peer Reviewed; Academic Journals:
SPORTDiscus
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement") AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination training" OR "combined training" OR plyometric* OR HIIT OR swimming) OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR cycling OR walking) AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR controlled) NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR "activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR "Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR "drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "crosssectional" OR "case report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR "cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats OR "epidemiology") CINAHL was searched with appropriate CINAHL subject headings incorporated into hedges, though not shown below, medical headings were included for "blood pressure", "exercise", "running", and "weight lifting". Filters were set for Research Article; Humans, All Adults. CINAHL hits excluded MEDLINE records.
CINAHL
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement") AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination training" OR "combined training" OR plyometric* OR HIIT OR swimming) OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR cycling OR walking) AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR controlled) NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR "activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR "Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR "drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "crosssectional" OR "case report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR "cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats OR "epidemiology") 
External Validity
Items satisfied=___ (3 possible points) § 15. Were subjects "blinded" to their assigned intervention until recruitment and baseline/ pre-training measurements were completed and final? (i.e., subjects were unaware of the intervention they had received until these processes were complete). Note. All analyses followed mixed-effects assumptions and models were fit using maximum-likelihood estimation. BP indicates blood pressure; CI, confidence interval; d + , weighted mean effect size; k, number of observations in the model; RT, resistance training. * Negative values indicate that RT reduced BP to a greater extent compared to the control group. † Comparisons were disaggregated for multi-treatment studies 2-8 (i.e., 2 different RT interventions were compared to a single control group); effect sizes (ds) were calculated for each comparison and analyzed as individual studies using Stata 13.1 9 (i.e., ds were considered independent). To determine whether dependence influenced our mean estimates, multivariate meta-analytic models that accounted for nonindependent ds were generated in R 10 using the metafor package (viz. rma.mv function), 11, 12 i.e., study identity was modelled as a randomeffect allowing the model to fit the data/treatment effects nested within a study. ‡ Sensitivity analysis revealed similar estimates between models, see bolded statistics, indicating that non-independent ds did not influence our mean estimates. § Tests for homogeneity: The Q statistic (or Cochran's Q) 13 indicates whether significant heterogeneity is present (or not). The I 2 statistic 14, 15 quantifies the amount of heterogeneity (i.e., the degree or level of inconsistency across results) that ranges from 0% to 100%; tentative cutpoints for low, moderate, and high correspond to 25%, 50%, and 75%, respectively. || Represents the weighted mean BP change for the RT group relative to control. [2] [3] [4] [5] [6] [7] [8] (i.e., 2 different RT interventions were compared to a single control group); effect sizes (ds) were calculated for each comparison and analyzed as individual studies using Stata 13.1 9 (i.e., ds were considered independent). To determine whether dependence influenced our model estimates, multivariate meta-analytic models that accounted for nonindependent ds were generated in R 10 using the metafor package (viz. rma.mv function), 11, 12 i.e., study identity was modelled as a randomeffect allowing the model to fit the data/treatment effects nested within a study. † Moderator variables were mean-centered in both models; all analyses followed mixed-effects assumptions and models were fit using maximum-likelihood estimation.
8 ‡ Estimates the magnitude of DBP reduction among the RT group relative to control for each moderator, held constant at their mean, while statistically controlling for the presence of the moderators listed in the table above. Sensitivity analysis revealed similar estimates between models, indicating that non-independent ds did not significantly influence our multiple moderator meta-regression findings. Progressive, full-body RT P: RT load increased 2-10% when >12 reps were completed in sets 2 and 3. Wait-list Con: For ethical consideration, Con participants were offered "Walking for a Healthy Heart -Our Guide to Help You Start a Regular Walking Program" and "Exercise and Your Heart -A Guide to Physical Activity' brochures from the American Heart Association" without further instruction. Notes. ─ indicates missing/unreported information; ∆, change; b/w, between; BP, blood pressure; con, control; core, exercises that targeted muscle groups other than UB/LB (i.e., abdominals, hips, lower/mid-back); CVD, cardiovascular disease; DBP, diastolic BP; heavy-load, high intensity; HTN, hypertension; LB, lower body; low-load, light intensity; M, men; MetS, metabolic syndrome; moderate-load, moderate intensity; NAFLD, non-alcoholic fatty liver disease; SBP, systolic BP; RCT, randomized controlled trial; RT, resistance training. RM, repetition maximum; T2DM, type 2 diabetes mellitus; UB, upper body; UK, United Kingdom; US, United States; W, women; X-RCT, cross-over design, RCT. * Study details: First Author, Publication Year (study design, geographical study location, total number of reported funding sources). † BP-focused primary study outcome. ‡ Sample characteristics: Number of RT and Con participants that started/completed the intervention (% of women or men), race/ethnicity, age (in years), body mass index (in kg/m 2 ), resting SBP/DBP (% reportedly taking BP medications), CVD-related chronic diseases and/or health conditions (if any). § Race/ethnicity: Racial/ethnic breakdown is italicized (% of the total sample) for the 9 studies that reported this information; when unreported, race/ethnicity was estimated based on the geographical study location. || CVD-related chronic diseases (T2DM, heart failure, CVD, NAFLD) and/or health conditions (HTN, dyslipidemia, obesity, MetS) are provided when applicable; if a subset of the sample has the disease and/or condition (but not all), the proportion is provided in parentheses. ¶ Intervention length (in weeks); the level of supervision is provided when possible. # BP ∆: Post -Pre = SBP/DBP (mmHg) change for the RT and Con groups at post-vs. pre-intervention (unweighted). RT vs. Con = Standardized mean SBP/DBP difference for the RT compared to Con group that was arithmetically back-translated (i.e., transformed) to the original metric, mmHg. -indicates the item is not applicable; k, number of observations; NS, not satisfied; UD, unable to determine. * Items could be fully or partially satisfied; 1 point was awarded to trials that fully satisfied these items; partially satisfied=0.5 points. † Reported as Mean ± SD (Median; Range=Minimum-Maximum values). ‡ Power=2 points were awarded to trials that fully satisfied Item 28; partially satisfied=1 point. Note. This model follows mixed-effects assumptions. BP indicates blood pressure; CI, confidence interval; k, number of observations in the model; min, minimum; max, maximum; RT, resistance training. * Weighted mean effect sizes (d + ) are negative when BP is at lower post-compared to pre-intervention (i.e., within-group) or when RT reduced BP to a greater extent than control (i.e., between-group). † Tests for homogeneity: The Q statistic (or Cochran's Q) 13 indicates whether significant heterogeneity is present (or not). The I 2 statistic 14,15 quantifies the amount of heterogeneity (i.e., the degree or level of inconsistency across results) that ranges from 0% to 100%; tentative cut-points for low, moderate, and high correspond to 25%, 50%, and 75%, respectively. ‡ BP Difference: Within-group represents the change in BP post-compared to pre-intervention; Between-group represents the change in BP post-compared to pre-intervention for RT relative to control. 
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